LONDON--(BUSINESS WIRE)--Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on first-in-class novel, non-steroidal anti-inflammatory drugs, announced today that Dr. Yuval Cohen, President of Morria, will deliver a presentation at the annual Atlas Venture Japan Biopharma Partnering Conference 2007, co-sponsored by Itochu Corp, NIF SMBC Ventures Co Ltd, Dechert LLP and EBD Group. The presentation will take place at 9:15am on Tuesday March 20th. The conference, by invitation only, will be held at the Park Hyatt Tokyo.
